Overview:
Bovine Tuberculosis (TB) occurs in cattle. This diseases results from infection of bacterium Mycobacterium bovis (M. bovis). This bacteria leads to diseases in various other mammals that also includes humans, goats, deer, dogs, cats and others. TB mainly affects respiratory system in cattle, however, its clinical signs are rarely observed. Bacille Calmette-Guerin (BCG) is a prototype vaccine developed for wildlife and domestic livestock. This strain of M. bovis is utilized in the BCG vaccine for percutaneous uses. This vaccines uses TICE strain (Bacillus of Calmette and Guerin) which is developed by the researchers at the University of Illinois from a Pasteur Institute.
Request Sample Report (Including Full TOC, Table & Figures) @
https://www.coherentmarketinsights.com/insight/request-sample/5242
Market Drivers:
Growing initiatives by government for veterinary tuberculosis vaccine is projected to propel growth of the global veterinary tuberculosis vaccine market during the forecast period. For instance, in July 2020, researchers from U.K. government research organization received approval from the Department of Environment, U.K. for conducting field trial for bovine tuberculosis TB cattle vaccine. The time period for field trial was 2021-2024 on behalf of the Welsh Government and the Scottish Government.
Furthermore, rise in R&D activities for tuberculosis vaccines is also anticipated to augment growth of the global veterinary tuberculosis vaccine market over the forecast period. For instance, in November 2019, the University of Surrey published an article regarding the research of novel vaccines created to treat bovine TB through a new vaccine and skin test for protecting cattle. The research studied the protective efficacy of the vaccine in guinea pigs.
Market Restraints:
Factors such as discontinuation in animal vaccinations are likely to impede growth of the global veterinary tuberculosis vaccine market. For instance, in April 2019, Wisconsin Department of Agriculture announced the discontinuation of Mycopar, which is a vaccine utilized in Johne’s disease in animals. This is the only licensed vaccine in the U.S., and its discontinuation is creating challenges in the market.
Impact of COVID-19:
The outbreak of COVID-19 pandemic has affected several economies around the world. In January 2020, the World Health Organization declared this a public health emergency. During the pandemic various market activities were hindered. However, due to the virus outbreak, demand for development of vaccines increased all over the world. The experiences of health professionals in animal health supported the development of as well as use of COVID-19 vaccines in domestic animal species. Thus, with increasing R&D for vaccine against coronavirus, the veterinary tuberculosis vaccine market was positively affected.
Regional Insights:
The global veterinary tuberculosis vaccine market is geographically divided into North America, Europe, Latin America, Asia Pacific and Middle East & Africa.
Asia Pacific among regions is anticipated to witness substantial growth in the global veterinary tuberculosis vaccine market during the forecast period. This growth can be attributed to rise in focus of market players on adoption of inorganic growth strategies including agreements with other players, and high prevalence of Bovine tuberculosis in the region. For instance, as per the article published in the journal Transboudary and Emerging Disease in 2017, India witnessed 7.3% prevalence of the bovine tuberculosis, and as per the World Animal Health Information System, bTB occurs in several regions of Asia.
Request PDF Brochure with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-pdf/5242
Major players active in the global veterinary tuberculosis vaccine market are Zoetis Inc., Merck KGaA, CZ Vaccines (Zendal), and Colorado Serum Company.
Reasons to buy this Veterinary Tuberculosis Vaccine Market Report
☑ It attempts an analysis of the competing scenario.
☑ The current and exceptional product revenue market.
☑ An in-depth data on the regional investigation and competitive landscape structure.
☑ It benefits in creating an awareness of the important key product segments.
☑ The marketing strategies, opportunities, and development factors are explained.
☑ Veterinary Tuberculosis Vaccine market size estimation and recent advancements in the industry are explained.
SPECIAL OFFER (Avail an Up-to 40% discount on this report ) @
https://www.coherentmarketinsights.com/insight/buy-now/5242
Table of Content
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunity
- Impact Analysis
- Key Developments
- Industry Trends
- Regulatory Scenario
- Recent Product Approval/Launches
- PEST Analysis
- Porter’s Analysis
- Market Dynamics
- Global Veterinary Tuberculosis Vaccine Market– Impact of Coronavirus (COVID-19) Pandemic
- Impact on Demand
- Impact on Healthcare
- Epidemiology
- Global Veterinary Tuberculosis Vaccine Market, By Type, 2017 – 2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 – 2030
- Segment Trends
- Live Attenuated
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Inactivated
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Mn)
- Introduction
- Global Veterinary Tuberculosis Vaccine Market, By Route of Administration, 2017 – 2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 – 2030
- Segment Trends
- Sub-cutaneous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Intramuscular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Mn)
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Mn)
- Introduction
- Global Veterinary Tuberculosis Vaccine Market, By Animal Type, 2017 – 2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 – 2030
- Segment Trends
- Cattle
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Dogs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Mn)
- Cats
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Mn)
- Introduction
- Global Veterinary Tuberculosis Vaccine Market, By Region, 2017 – 2030 (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2022 and 2030(%)
- Y-o-Y Growth Analysis, For Regions, 2017 – 2030
- Regional Trends
- North America
- Market Size and Forecast, By Type, 2017 – 2030 (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 – 2030 (US$ Mn)
- Market Size and Forecast, By Animal Type, 2017 – 2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2030 (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Type, 2017 – 2030 (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 – 2030 (US$ Mn)
- Market Size and Forecast, By Animal Type, 2017 – 2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2030 (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Type, 2017 – 2030 (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 – 2030 (US$ Mn)
- Market Size and Forecast, By Animal Type, 2017 – 2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2030 (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Type, 2017 – 2030 (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 – 2030 (US$ Mn)
- Market Size and Forecast, By Animal Type, 2017 – 2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2030 (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Market Size and Forecast, By Type, 2017 – 2030 (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 – 2030 (US$ Mn)
- Market Size and Forecast, By Animal Type, 2017 – 2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2030 (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Type, 2017 – 2030 (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 – 2030 (US$ Mn)
- Market Size and Forecast, By Animal Type, 2017 – 2030 (US$ Mn)
- Market Size and Forecast, By Region/Country, 2017 – 2030 (US$ Mn)
- South Africa
- Central Africa
- North Africa
- Introduction
- Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Colorado Serum Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- CZ Vaccines (Zendal)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Zoetis Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Merck KGaA
- Analyst Views
- Section
- Research Methodology
- About Us
About Coherent Market Insights
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837